Sign in
4

Changes in Ownership

Mirum Pharmaceuticals, Inc. Filed Acc 0001209191-23-035831

Director sold 14,608 shares at $29.00 ($423,632)

  • Director acquired 14,608 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
GREY MICHAEL G Director 2023-06-08 Option exercise 10b5-1 +14,608 $2.94 $42,889 14,608 D
GREY MICHAEL G Director 2023-06-08 Sale 10b5-1 −14,608 $29.00 $423,632 0 D
Derivatives
GREY MICHAEL G Director 2023-06-08 Option exercise · Stock Option (right to buy) 10b5-1 −14,608 345,784 D
Open-market sales · 14,608 sh · avg $29.00 · $423,632
Loading xslF345X04/doc4.xml…